Quantinno Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $462K | Buy |
14,673
+4,302
| +41% | +$136K | ﹤0.01% | 1684 |
|
|
2025
Q1 | $340K | Buy |
10,371
+1,970
| +23% | +$64.5K | ﹤0.01% | 1565 |
|
|
2024
Q4 | $304K | Buy |
8,401
+864
| +11% | +$31.2K | ﹤0.01% | 1379 |
|
|
2024
Q3 | $235K | Sell |
7,537
-68
| -0.9% | -$2.12K | ﹤0.01% | 1340 |
|
|
2024
Q2 | $203K | Buy |
7,605
+835
| +12% | +$22.3K | ﹤0.01% | 1262 |
|
|
2024
Q1 | $231K | Buy |
+6,770
| New | +$231K | 0.01% | 1148 |
|
|
2023
Q2 | – | Sell |
-6,305
| Closed | -$228K | – | 948 |
|
|
2023
Q1 | $228K | Hold |
6,305
| – | – | 0.02% | 790 |
|
|
2022
Q4 | $225K | Sell |
6,305
-14
| -0.2% | -$500 | 0.02% | 757 |
|
|
2022
Q3 | $214K | Buy |
+6,319
| New | +$214K | 0.03% | 561 |
|
|
2021
Q4 | – | Sell |
-10,188
| Closed | -$272K | – | 548 |
|
|
2021
Q3 | $272K | Hold |
10,188
| – | – | 0.3% | 164 |
|
|
2021
Q2 | $314K | Hold |
10,188
| – | – | 0.36% | 144 |
|
|
2021
Q1 | $267K | Sell |
10,188
-10,119
| -50% | -$265K | 0.29% | 188 |
|
|
2020
Q4 | $511K | Sell |
20,307
-6,732
| -25% | -$169K | 0.4% | 73 |
|
|
2020
Q3 | $563K | Buy |
+27,039
| New | +$563K | 0.38% | 71 |
|
|
2020
Q2 | – | Sell |
-35,663
| Closed | -$642K | – | 448 |
|
|
2020
Q1 | $642K | Buy |
+35,663
| New | +$642K | 0.4% | 60 |
|
|
2019
Q4 | – | Sell |
-14,482
| Closed | -$398K | – | 492 |
|
|
2019
Q3 | $398K | Buy |
+14,482
| New | +$398K | 0.27% | 167 |
|